August 19, 2020 - Roche (Basel, Switzerland) and Regeneron are partnering to develop, manufacture and distribute REGN-COV2, Regeneron’s investigational antiviral antibody combination against COVID-19, to people around the globe. According to the companies, REGN-COV2 “could provide a much-needed treatment option for people already experiencing symptoms of COVID-19, and also … [Read more...]